Results for “”
Showing 31 to 40 of 128 resultsWeb Security Policy
Updated: October 18, 2022
The Leukemia & Lymphoma Society of Canada (LLSC) goes to great lengths to protect the confidentiality and integrity of any personal information you share with us on the web.
COVID-19 Vaccine update for the blood cancer community
Updated: September 14, 2022
Studies are underway to better understand vaccine efficacy in the blood cancer population but we know vaccines are safe and effective in the majority of people affected by blood cancers.
COVID-19
Vaccination Policy Announcement
Updated: March 15, 2022
As each province loosens restrictions for businesses and public spaces, we are taking an added step to further support the safety of individuals with a blood cancer, their family members, healthcare professionals, and our supporters with a new vaccination policy.
COVID-19
Pediatric Blood Cancer Research Innovation Grant
Updated: September 12, 2022
Canadian researchers are invited to submit proposals to The Leukemia & Lymphoma Society of Canada’s Pediatric Blood Cancer Research Innovation Grant Competition. This grant is designed to challenge the current pediatric blood cancer landscape by providing funding for project...
Blood Cancer Quality of Life Grant
Updated: September 13, 2022
Canadian researchers are invited to submit proposals to The Leukemia & Lymphoma Society of Canada’s Blood Cancer Quality of Life Grant Competition.
Current and past funded research
Updated: November 10, 2022
Learn more about current and past research Investments.